肥満治療機器のグローバル市場展望2022-2028

• 英文タイトル:Obesity Intervention Devices Market, Global Outlook and Forecast 2022-2028

Obesity Intervention Devices Market, Global Outlook and Forecast 2022-2028「肥満治療機器のグローバル市場展望2022-2028」(市場規模、市場予測)調査レポートです。• レポートコード:MR2211MG10823
• 出版社/出版日:Market Monitor Global / 2022年11月
• レポート形態:英文、PDF、65ページ
• 納品方法:Eメール(納期:2-3日)
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥481,000 (USD3,250)▷ お問い合わせ
  Enterprise User¥625,300 (USD4,225)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査資料は次の情報を含め、肥満治療機器のグローバル市場規模と予測を記載しています。・肥満治療機器のグローバル市場:売上、2017年-2022年、2023年-2028年
・肥満治療機器のグローバル市場:販売量、2017年-2022年、2023年-2028年
・世界のトップ5企業、2021年

肥満治療機器のグローバル市場規模は2021年に000Mドルと評価され、予測期間中に000%のCAGRで2028年までに000Mドルに達すると予測されています。米国市場は2021年に000Mドルと推定されており、中国は2028年までに000Mドルに達すると予測されています。「胃バンド」セグメントは今後6年間、000%のCAGRで2028年までに000Mドルに成長すると予測されています。

肥満治療機器のグローバル主要企業は、Medtronic、EnteroMedics、Apollo Endosurgery、Cousin Biotech、Aspire Bariatrics、Obalon Therapeutics、GI Dynamics、Johnson and Johnson、Spatz FGIA、Gore Medical、ReShape Lifesciencesなどです。2021年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル(MMG)社は、肥満治療機器のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の肥満治療機器市場:タイプ別、2017年-2022年、2023年-2028年
世界の肥満治療機器市場:タイプ別市場シェア、2021年
・胃バンド、電気刺激システム、胃バルーンシステム、胃排出システム、食欲抑制剤

世界の肥満治療機器市場:用途別、2017年-2022年、2023年-2028年
世界の肥満治療機器市場:用途別市場シェア、2021年
・病院、消化器内科クリニック、外来手術センター

世界の肥満治療機器市場:地域・国別、2017年-2022年、2023年-2028年
世界の肥満治療機器市場:地域別市場シェア、2021年
・北米:アメリカ、カナダ、メキシコ
・ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
・アジア:中国、日本、韓国、東南アジア、インド
・南米:ブラジル、アルゼンチン
・中東・アフリカ:トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における肥満治療機器のグローバル売上、2017年-2022年
・主要企業における肥満治療機器のグローバル売上シェア、2021年
・主要企業における肥満治療機器のグローバル販売量、2017年-2022年
・主要企業における肥満治療機器のグローバル販売量シェア、2021年

さらに、当レポートは主要企業のプロファイルを提示します。
Medtronic、EnteroMedics、Apollo Endosurgery、Cousin Biotech、Aspire Bariatrics、Obalon Therapeutics、GI Dynamics、Johnson and Johnson、Spatz FGIA、Gore Medical、ReShape Lifesciences

*************************************************************

・調査・分析レポートの概要
肥満治療機器市場の定義
市場セグメント
世界の肥満治療機器市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の肥満治療機器市場規模
世界の肥満治療機器市場規模:2021年 VS 2028年
世界の肥満治療機器市場規模と予測 2017年-2028年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの肥満治療機器の売上
グローバルトップ3およびトップ5企業、2021年売上ベース
グローバル企業の肥満治療機器製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分:胃バンド、電気刺激システム、胃バルーンシステム、胃排出システム、食欲抑制剤
肥満治療機器のタイプ別グローバル売上・予測

・用途別市場分析
用途区分:病院、消化器内科クリニック、外来手術センター
肥満治療機器の用途別グローバル売上・予測

・地域別市場分析
地域別肥満治療機器市場規模 2021年と2028年
地域別肥満治療機器売上・予測
北米市場
- アメリカの肥満治療機器市場規模2017年-2028年
- カナダの肥満治療機器市場規模2017年-2028年
- メキシコの肥満治療機器市場規模2017年-2028年
ヨーロッパ市場
- ドイツの肥満治療機器市場規模2017年-2028年
- フランスの肥満治療機器市場規模2017年-2028年
- イギリスの肥満治療機器市場規模2017年-2028年
- イタリアの肥満治療機器市場規模2017年-2028年
- ロシアの肥満治療機器市場規模2017年-2028年
アジア市場
- 中国の肥満治療機器市場規模2017年-2028年
- 日本の肥満治療機器市場規模2017年-2028年
- 韓国の肥満治療機器市場規模2017年-2028年
- 東南アジアの肥満治療機器市場規模2017年-2028年
- インドの肥満治療機器市場規模2017年-2028年
南米市場
- ブラジルの肥満治療機器市場規模2017年-2028年
- アルゼンチンの肥満治療機器市場規模2017年-2028年
中東・アフリカ市場
- トルコの肥満治療機器市場規模2017年-2028年
- イスラエルの肥満治療機器市場規模2017年-2028年
- サウジアラビアの肥満治療機器市場規模2017年-2028年
- UAEの肥満治療機器市場規模2017年-2028年

・主要企業のプロファイル(企業概要、事業概要、主要製品、売上、ニュースなど)
Medtronic、EnteroMedics、Apollo Endosurgery、Cousin Biotech、Aspire Bariatrics、Obalon Therapeutics、GI Dynamics、Johnson and Johnson、Spatz FGIA、Gore Medical、ReShape Lifesciences
...

Obesity is a medical condition caused by an increase in fat cells in the body, which can have a negative impact on health. High blood pressure, high cholesterol and heart disease are serious medical conditions associated with obesity. Obesity also increases the risk of certain diseases, such as type 2 diabetes, osteoarthritis, obstructive sleep apnea, and depression. If diet or exercise is not effective, obesity intervention devices can be used to reduce the size of the stomach or the length of the intestine, thereby reducing the ability to absorb nutrients from food.
This report contains market size and forecasts of Obesity Intervention Devices in Global, including the following market information:
Global Obesity Intervention Devices Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Obesity Intervention Devices market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Gastric Bands Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Obesity Intervention Devices include Medtronic, EnteroMedics, Apollo Endosurgery, Cousin Biotech, Aspire Bariatrics, Obalon Therapeutics, GI Dynamics, Johnson and Johnson and Spatz FGIA, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Obesity Intervention Devices companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Obesity Intervention Devices Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Obesity Intervention Devices Market Segment Percentages, by Type, 2021 (%)
Gastric Bands
Electrical Stimulation System
Gastric Balloon System
Gastric Emptying System
Appetite Suppressors
Global Obesity Intervention Devices Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Obesity Intervention Devices Market Segment Percentages, by Application, 2021 (%)
Hospitals
Gastroenterology clinics
Ambulatory Surgical Centers
Global Obesity Intervention Devices Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Obesity Intervention Devices Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Obesity Intervention Devices revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Obesity Intervention Devices revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Medtronic
EnteroMedics
Apollo Endosurgery
Cousin Biotech
Aspire Bariatrics
Obalon Therapeutics
GI Dynamics
Johnson and Johnson
Spatz FGIA
Gore Medical
ReShape Lifesciences

レポート目次

1 Introduction to Research & Analysis Reports
1.1 Obesity Intervention Devices Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Obesity Intervention Devices Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Obesity Intervention Devices Overall Market Size
2.1 Global Obesity Intervention Devices Market Size: 2021 VS 2028
2.2 Global Obesity Intervention Devices Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Obesity Intervention Devices Players in Global Market
3.2 Top Global Obesity Intervention Devices Companies Ranked by Revenue
3.3 Global Obesity Intervention Devices Revenue by Companies
3.4 Top 3 and Top 5 Obesity Intervention Devices Companies in Global Market, by Revenue in 2021
3.5 Global Companies Obesity Intervention Devices Product Type
3.6 Tier 1, Tier 2 and Tier 3 Obesity Intervention Devices Players in Global Market
3.6.1 List of Global Tier 1 Obesity Intervention Devices Companies
3.6.2 List of Global Tier 2 and Tier 3 Obesity Intervention Devices Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type – Global Obesity Intervention Devices Market Size Markets, 2021 & 2028
4.1.2 Gastric Bands
4.1.3 Electrical Stimulation System
4.1.4 Gastric Balloon System
4.1.5 Gastric Emptying System
4.1.6 Appetite Suppressors
4.2 By Type – Global Obesity Intervention Devices Revenue & Forecasts
4.2.1 By Type – Global Obesity Intervention Devices Revenue, 2017-2022
4.2.2 By Type – Global Obesity Intervention Devices Revenue, 2023-2028
4.2.3 By Type – Global Obesity Intervention Devices Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Obesity Intervention Devices Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Gastroenterology clinics
5.1.4 Ambulatory Surgical Centers
5.2 By Application – Global Obesity Intervention Devices Revenue & Forecasts
5.2.1 By Application – Global Obesity Intervention Devices Revenue, 2017-2022
5.2.2 By Application – Global Obesity Intervention Devices Revenue, 2023-2028
5.2.3 By Application – Global Obesity Intervention Devices Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region – Global Obesity Intervention Devices Market Size, 2021 & 2028
6.2 By Region – Global Obesity Intervention Devices Revenue & Forecasts
6.2.1 By Region – Global Obesity Intervention Devices Revenue, 2017-2022
6.2.2 By Region – Global Obesity Intervention Devices Revenue, 2023-2028
6.2.3 By Region – Global Obesity Intervention Devices Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country – North America Obesity Intervention Devices Revenue, 2017-2028
6.3.2 US Obesity Intervention Devices Market Size, 2017-2028
6.3.3 Canada Obesity Intervention Devices Market Size, 2017-2028
6.3.4 Mexico Obesity Intervention Devices Market Size, 2017-2028
6.4 Europe
6.4.1 By Country – Europe Obesity Intervention Devices Revenue, 2017-2028
6.4.2 Germany Obesity Intervention Devices Market Size, 2017-2028
6.4.3 France Obesity Intervention Devices Market Size, 2017-2028
6.4.4 U.K. Obesity Intervention Devices Market Size, 2017-2028
6.4.5 Italy Obesity Intervention Devices Market Size, 2017-2028
6.4.6 Russia Obesity Intervention Devices Market Size, 2017-2028
6.4.7 Nordic Countries Obesity Intervention Devices Market Size, 2017-2028
6.4.8 Benelux Obesity Intervention Devices Market Size, 2017-2028
6.5 Asia
6.5.1 By Region – Asia Obesity Intervention Devices Revenue, 2017-2028
6.5.2 China Obesity Intervention Devices Market Size, 2017-2028
6.5.3 Japan Obesity Intervention Devices Market Size, 2017-2028
6.5.4 South Korea Obesity Intervention Devices Market Size, 2017-2028
6.5.5 Southeast Asia Obesity Intervention Devices Market Size, 2017-2028
6.5.6 India Obesity Intervention Devices Market Size, 2017-2028
6.6 South America
6.6.1 By Country – South America Obesity Intervention Devices Revenue, 2017-2028
6.6.2 Brazil Obesity Intervention Devices Market Size, 2017-2028
6.6.3 Argentina Obesity Intervention Devices Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Obesity Intervention Devices Revenue, 2017-2028
6.7.2 Turkey Obesity Intervention Devices Market Size, 2017-2028
6.7.3 Israel Obesity Intervention Devices Market Size, 2017-2028
6.7.4 Saudi Arabia Obesity Intervention Devices Market Size, 2017-2028
6.7.5 UAE Obesity Intervention Devices Market Size, 2017-2028
7 Players Profiles
7.1 Medtronic
7.1.1 Medtronic Corporate Summary
7.1.2 Medtronic Business Overview
7.1.3 Medtronic Obesity Intervention Devices Major Product Offerings
7.1.4 Medtronic Obesity Intervention Devices Revenue in Global Market (2017-2022)
7.1.5 Medtronic Key News
7.2 EnteroMedics
7.2.1 EnteroMedics Corporate Summary
7.2.2 EnteroMedics Business Overview
7.2.3 EnteroMedics Obesity Intervention Devices Major Product Offerings
7.2.4 EnteroMedics Obesity Intervention Devices Revenue in Global Market (2017-2022)
7.2.5 EnteroMedics Key News
7.3 Apollo Endosurgery
7.3.1 Apollo Endosurgery Corporate Summary
7.3.2 Apollo Endosurgery Business Overview
7.3.3 Apollo Endosurgery Obesity Intervention Devices Major Product Offerings
7.3.4 Apollo Endosurgery Obesity Intervention Devices Revenue in Global Market (2017-2022)
7.3.5 Apollo Endosurgery Key News
7.4 Cousin Biotech
7.4.1 Cousin Biotech Corporate Summary
7.4.2 Cousin Biotech Business Overview
7.4.3 Cousin Biotech Obesity Intervention Devices Major Product Offerings
7.4.4 Cousin Biotech Obesity Intervention Devices Revenue in Global Market (2017-2022)
7.4.5 Cousin Biotech Key News
7.5 Aspire Bariatrics
7.5.1 Aspire Bariatrics Corporate Summary
7.5.2 Aspire Bariatrics Business Overview
7.5.3 Aspire Bariatrics Obesity Intervention Devices Major Product Offerings
7.5.4 Aspire Bariatrics Obesity Intervention Devices Revenue in Global Market (2017-2022)
7.5.5 Aspire Bariatrics Key News
7.6 Obalon Therapeutics
7.6.1 Obalon Therapeutics Corporate Summary
7.6.2 Obalon Therapeutics Business Overview
7.6.3 Obalon Therapeutics Obesity Intervention Devices Major Product Offerings
7.6.4 Obalon Therapeutics Obesity Intervention Devices Revenue in Global Market (2017-2022)
7.6.5 Obalon Therapeutics Key News
7.7 GI Dynamics
7.7.1 GI Dynamics Corporate Summary
7.7.2 GI Dynamics Business Overview
7.7.3 GI Dynamics Obesity Intervention Devices Major Product Offerings
7.7.4 GI Dynamics Obesity Intervention Devices Revenue in Global Market (2017-2022)
7.7.5 GI Dynamics Key News
7.8 Johnson and Johnson
7.8.1 Johnson and Johnson Corporate Summary
7.8.2 Johnson and Johnson Business Overview
7.8.3 Johnson and Johnson Obesity Intervention Devices Major Product Offerings
7.8.4 Johnson and Johnson Obesity Intervention Devices Revenue in Global Market (2017-2022)
7.8.5 Johnson and Johnson Key News
7.9 Spatz FGIA
7.9.1 Spatz FGIA Corporate Summary
7.9.2 Spatz FGIA Business Overview
7.9.3 Spatz FGIA Obesity Intervention Devices Major Product Offerings
7.9.4 Spatz FGIA Obesity Intervention Devices Revenue in Global Market (2017-2022)
7.9.5 Spatz FGIA Key News
7.10 Gore Medical
7.10.1 Gore Medical Corporate Summary
7.10.2 Gore Medical Business Overview
7.10.3 Gore Medical Obesity Intervention Devices Major Product Offerings
7.10.4 Gore Medical Obesity Intervention Devices Revenue in Global Market (2017-2022)
7.10.5 Gore Medical Key News
7.11 ReShape Lifesciences
7.11.1 ReShape Lifesciences Corporate Summary
7.11.2 ReShape Lifesciences Business Overview
7.11.3 ReShape Lifesciences Obesity Intervention Devices Major Product Offerings
7.11.4 ReShape Lifesciences Obesity Intervention Devices Revenue in Global Market (2017-2022)
7.11.5 ReShape Lifesciences Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Obesity Intervention Devices Market Opportunities & Trends in Global Market
Table 2. Obesity Intervention Devices Market Drivers in Global Market
Table 3. Obesity Intervention Devices Market Restraints in Global Market
Table 4. Key Players of Obesity Intervention Devices in Global Market
Table 5. Top Obesity Intervention Devices Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Obesity Intervention Devices Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Obesity Intervention Devices Revenue Share by Companies, 2017-2022
Table 8. Global Companies Obesity Intervention Devices Product Type
Table 9. List of Global Tier 1 Obesity Intervention Devices Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Obesity Intervention Devices Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Obesity Intervention Devices Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Obesity Intervention Devices Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Obesity Intervention Devices Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Obesity Intervention Devices Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Obesity Intervention Devices Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Obesity Intervention Devices Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Obesity Intervention Devices Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Obesity Intervention Devices Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Obesity Intervention Devices Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Obesity Intervention Devices Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Obesity Intervention Devices Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Obesity Intervention Devices Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Obesity Intervention Devices Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Obesity Intervention Devices Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Obesity Intervention Devices Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Obesity Intervention Devices Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Obesity Intervention Devices Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Obesity Intervention Devices Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Obesity Intervention Devices Revenue, (US$, Mn), 2023-2028
Table 30. Medtronic Corporate Summary
Table 31. Medtronic Obesity Intervention Devices Product Offerings
Table 32. Medtronic Obesity Intervention Devices Revenue (US$, Mn), (2017-2022)
Table 33. EnteroMedics Corporate Summary
Table 34. EnteroMedics Obesity Intervention Devices Product Offerings
Table 35. EnteroMedics Obesity Intervention Devices Revenue (US$, Mn), (2017-2022)
Table 36. Apollo Endosurgery Corporate Summary
Table 37. Apollo Endosurgery Obesity Intervention Devices Product Offerings
Table 38. Apollo Endosurgery Obesity Intervention Devices Revenue (US$, Mn), (2017-2022)
Table 39. Cousin Biotech Corporate Summary
Table 40. Cousin Biotech Obesity Intervention Devices Product Offerings
Table 41. Cousin Biotech Obesity Intervention Devices Revenue (US$, Mn), (2017-2022)
Table 42. Aspire Bariatrics Corporate Summary
Table 43. Aspire Bariatrics Obesity Intervention Devices Product Offerings
Table 44. Aspire Bariatrics Obesity Intervention Devices Revenue (US$, Mn), (2017-2022)
Table 45. Obalon Therapeutics Corporate Summary
Table 46. Obalon Therapeutics Obesity Intervention Devices Product Offerings
Table 47. Obalon Therapeutics Obesity Intervention Devices Revenue (US$, Mn), (2017-2022)
Table 48. GI Dynamics Corporate Summary
Table 49. GI Dynamics Obesity Intervention Devices Product Offerings
Table 50. GI Dynamics Obesity Intervention Devices Revenue (US$, Mn), (2017-2022)
Table 51. Johnson and Johnson Corporate Summary
Table 52. Johnson and Johnson Obesity Intervention Devices Product Offerings
Table 53. Johnson and Johnson Obesity Intervention Devices Revenue (US$, Mn), (2017-2022)
Table 54. Spatz FGIA Corporate Summary
Table 55. Spatz FGIA Obesity Intervention Devices Product Offerings
Table 56. Spatz FGIA Obesity Intervention Devices Revenue (US$, Mn), (2017-2022)
Table 57. Gore Medical Corporate Summary
Table 58. Gore Medical Obesity Intervention Devices Product Offerings
Table 59. Gore Medical Obesity Intervention Devices Revenue (US$, Mn), (2017-2022)
Table 60. ReShape Lifesciences Corporate Summary
Table 61. ReShape Lifesciences Obesity Intervention Devices Product Offerings
Table 62. ReShape Lifesciences Obesity Intervention Devices Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Obesity Intervention Devices Segment by Type in 2021
Figure 2. Obesity Intervention Devices Segment by Application in 2021
Figure 3. Global Obesity Intervention Devices Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Obesity Intervention Devices Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Obesity Intervention Devices Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Obesity Intervention Devices Revenue in 2021
Figure 8. By Type - Global Obesity Intervention Devices Revenue Market Share, 2017-2028
Figure 9. By Application - Global Obesity Intervention Devices Revenue Market Share, 2017-2028
Figure 10. By Region - Global Obesity Intervention Devices Revenue Market Share, 2017-2028
Figure 11. By Country - North America Obesity Intervention Devices Revenue Market Share, 2017-2028
Figure 12. US Obesity Intervention Devices Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Obesity Intervention Devices Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Obesity Intervention Devices Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Obesity Intervention Devices Revenue Market Share, 2017-2028
Figure 16. Germany Obesity Intervention Devices Revenue, (US$, Mn), 2017-2028
Figure 17. France Obesity Intervention Devices Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Obesity Intervention Devices Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Obesity Intervention Devices Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Obesity Intervention Devices Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Obesity Intervention Devices Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Obesity Intervention Devices Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Obesity Intervention Devices Revenue Market Share, 2017-2028
Figure 24. China Obesity Intervention Devices Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Obesity Intervention Devices Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Obesity Intervention Devices Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Obesity Intervention Devices Revenue, (US$, Mn), 2017-2028
Figure 28. India Obesity Intervention Devices Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Obesity Intervention Devices Revenue Market Share, 2017-2028
Figure 30. Brazil Obesity Intervention Devices Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Obesity Intervention Devices Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Obesity Intervention Devices Revenue Market Share, 2017-2028
Figure 33. Turkey Obesity Intervention Devices Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Obesity Intervention Devices Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Obesity Intervention Devices Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Obesity Intervention Devices Revenue, (US$, Mn), 2017-2028
Figure 37. Medtronic Obesity Intervention Devices Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. EnteroMedics Obesity Intervention Devices Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Apollo Endosurgery Obesity Intervention Devices Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Cousin Biotech Obesity Intervention Devices Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Aspire Bariatrics Obesity Intervention Devices Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Obalon Therapeutics Obesity Intervention Devices Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. GI Dynamics Obesity Intervention Devices Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Johnson and Johnson Obesity Intervention Devices Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Spatz FGIA Obesity Intervention Devices Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Gore Medical Obesity Intervention Devices Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. ReShape Lifesciences Obesity Intervention Devices Revenue Year Over Year Growth (US$, Mn) & (2017-2022)




• 英文レポート名:Obesity Intervention Devices Market, Global Outlook and Forecast 2022-2028
• 日本語訳:肥満治療機器のグローバル市場展望2022-2028
• レポートコード:MR2211MG10823お問い合わせ(見積依頼・ご注文・質問)